Evidence map›Paper›PMID 40642001›Full record

ArticleFrontiers in pharmacology2025

Influence of probiotics and deoxycholate on azathioprine transport in the PAMPA model: insights into pharmacomicrobiomics and interindividual variability in drug response.

Maja Đanić, Nebojša Pavlović, Natalija Dedić, Dragana Zaklan, Slavica Lazarević, Bojan Stanimirov, Momir Mikov

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maja ĐanićDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Nebojša PavlovićDepartment of Pharmacy, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Natalija DedićFaculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Dragana ZaklanDepartment of Pharmacy, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Slavica LazarevićDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Bojan StanimirovDepartment of Biochemistry, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Momir MikovDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Interindividual variability in drug response presents a major clinical challenge, necessitating a deeper understanding of contributing factors. While the role of gut microbiota, probiotics and bile acids in modulating drug metabolism, absorption, and bioavailability is increasingly recognized, their precise impact on variability remains an active area of research. Azathioprine, a widely used immunosuppressant for inflammatory bowel disease, exhibits significant variability in patient response. This study investigates the effects of probiotic bacteria and sodium deoxycholate (DC) on azathioprine permeability to elucidate mechanisms underlying interindividual differences in drug absorption and therapeutic outcomes. Methods: The parallel artificial membrane permeability assay (PAMPA) was used to evaluate the permeability of azathioprine at pH 5.8, 6.5, and 7.4, both alone and in combination with DC and probiotics. Following a six-hour incubation, azathioprine concentrations were quantified using high-performance liquid chromatography (HPLC), and permeability coefficients were calculated. Additionally, molecular mechanics (MM2) calculations were performed to analyze interactions between azathioprine and bile acids. Chemoinformatics-based platforms, pkCSM and ADMETsar, were used to predict the interactions of azathioprine and DC with drug transporters in the gastrointestinal tract, particularly P-glycoprotein (P-gp). Results: Azathioprine exhibited higher permeability at lower pH values. The presence of probiotic bacteria resulted in a statistically significant increase in azathioprine permeability; however, the total amount of azathioprine during incubation with bacteria significantly decreased. DC reduced drug permeability, with higher DC concentrations leading to a greater decrease in azathioprine permeability, as reflected by lower drug levels in the acceptor compartment, likely due to the formation of hydrophilic complexes with azathioprine, which exhibit lower membrane permeability compared to the free drug. Conclusion: The findings indicate significant interactions between probiotic bacteria, DC, and azathioprine that may affect azathioprine absorption. Since the PAMPA method is exclusively suited for evaluating passive transport, additional

Indexed as

azathioprinedrug optimizationdrug transportinflammatory bowel diseaseintestinal microbiotapermeabilityprobiotics

Identifiers

PMID40642001
PMCPMC12240781

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.